A Tokushima University-spinoff startup developing digital dental crown technology that treats teeth without grinding healthy enamel. By designing crowns that only replace necessary parts, it provides solutions to dental clinics, with adoption at 250 clinics nationwide, contributing to reduced patient costs and improved treatment precision.
徳島大学発スタートアップの株式会社amidex（本社：徳島県徳島市、代表取締役：伊原 晃、以下amidex）は、このたびプレシリーズAラウンドにおいて、総額1.2億円の資金調達（エクイティ）を実施いたしました。こ...
[画像1: https://prtimes.jp/i/147339/6/resize/d147339-6-26d436e0f36f046a5fd8-3.png ] 導入歯科医院数が、全国で250院を突破した「Amidex(TM)」。 株式会社amidex 創立2周年のご挨拶 株式会社amidex（本社：...
株式会社amidex（本社：徳島県徳島市、代表取締役CEO：伊原晃、以下amidex）は、2025年2月18日・19日に開催された「Industry Co-Creationサミット FUKUOKA 2025（ICC FUKUOKA 2025）デザイン&イノベーション...
[画像: https://prtimes.jp/i/147339/2/resize/d147339-2-b1e06671dfdc76b62a57-0.jpg ] 東京科学大学 田上順次名誉教授東京科学大学 田上順次名誉教授 顧問就任について 田上先生は、1995年から2021年まで東京...
株式会社amidex（本社：徳島県徳島市、代表取締役CEO：伊原晃、以下amidex）は、株式会社産学連携キャピタルよりシードラウンドの資金調達（金額非公表）を実施したことをお知らせします。 今回の資金調達に...
A startup developing 3D game-based medical devices to comprehensively assess and treat executive function in children with ADHD. By combining game design with neuroscience, it advances digital transformation in healthcare and expands possibilities for supporting diverse children.
On March 2, 2022, Serendix completed Japan’s first 3D-printed house in just 23 hours and 12 minutes. In September 2024, the company built the first unit of the “serendix50,” a home designed for two-person households, in Suzu City, Ishikawa Prefecture. Also in 2024, Serendix began constructing reconstruction housing in Ukraine as part of the “Japan-Ukraine Economic Reconstruction Promotion Conference.” In addition to housing, Serendix is expanding into other areas, including a project in partnership with the JR West Group to build the world’s first 3D-printed train station.
We develop, manufacture, and sell wireless power transfer systems that wirelessly supply several watts of power to locations several meters away. Our unique and superior microwave wireless power transfer technologies eliminate power wires and charging and make a society where a variety of devices can use power efficiently anywhere. We manufacture and sell power transmitter and receiver systems that comply with the current regulations. These systems transmit power wirelessly to IoT sensors and small actuators in facilities and equipment in factories, warehouses, distribution centers, etc. We are also developing higher-performance wireless power transfer systems.
KDDD (Kyoto Drug Discovery and Development) is a spin-off company from Kyoto University. Our project is based on a result of research by Department of Ophthalmology Kyoto University and Graduate School of Biostudies. We sincerely aim to develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
